tiprankstipranks
Trending News
More News >
Corline Biomedical AB (SE:CLBIO)
:CLBIO
Sweden Market
Advertisement

Corline Biomedical AB (CLBIO) Income Statement

Compare
0 Followers

Corline Biomedical AB Income Statement

Last quarter (Q2 2025), Corline Biomedical AB's total revenue was kr2.19M, a decrease of -3.02% from the same quarter last year. In Q2, Corline Biomedical AB's net income was kr-3.26M. See Corline Biomedical AB’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
kr 9.78Mkr 25.03Mkr 23.55Mkr 7.06Mkr 3.70M
Gross Profit
kr 13.44Mkr 28.38Mkr 22.73Mkr 9.10Mkr 10.32M
Operating Expenses
kr 36.61Mkr 30.17Mkr 20.40Mkr 11.13Mkr 17.61M
Depreciation and Amortization
kr 95.00Kkr 97.00Kkr 56.00Kkr 31.00Kkr 14.00K
EBITDA
kr -23.07Mkr -1.69Mkr 2.38Mkr -6.88Mkr -7.27M
Operating Income
kr -23.17Mkr -1.79Mkr 2.33Mkr -6.91Mkr -7.29M
Other Income/Expenses
kr -28.00Kkr -21.00Kkr 0.00kr -13.00Kkr 0.00
Pretax Income
kr -23.19Mkr -1.81Mkr 2.33Mkr -6.92Mkr -7.29M
Net Income
kr -23.19Mkr -1.81Mkr 2.33Mkr -6.92Mkr -7.29M
Per Share Metrics
Basic EPS
kr -1.06kr -0.08kr 0.11kr -0.34kr -0.42
Diluted EPS
kr -1.06kr -0.08kr 0.11kr -0.34kr -0.42
Weighted Average Shares Outstanding
21.81M 21.49M 21.49M 20.44M 17.15M
Weighted Average Shares Outstanding (Diluted)
21.81M 21.68M 21.49M 20.44M 17.15M
Currency in SEK

Corline Biomedical AB Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis